1. Home
  2. UHT vs EOLS Comparison

UHT vs EOLS Comparison

Compare UHT & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Health Realty Income Trust

UHT

Universal Health Realty Income Trust

HOLD

Current Price

$41.84

Market Cap

628.5M

Sector

Real Estate

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$8.78

Market Cap

550.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UHT
EOLS
Founded
1986
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
628.5M
550.9M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
UHT
EOLS
Price
$41.84
$8.78
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$43.00
$15.50
AVG Volume (30 Days)
88.8K
953.4K
Earning Date
04-27-2026
05-04-2026
Dividend Yield
7.33%
N/A
EPS Growth
N/A
1.23
EPS
0.79
N/A
Revenue
$99,190,000.00
$297,176,000.00
Revenue This Year
$2.12
$13.27
Revenue Next Year
$2.94
$17.62
P/E Ratio
$52.20
N/A
Revenue Growth
0.18
11.61
52 Week Low
$35.26
$3.86
52 Week High
$46.30
$8.69

Technical Indicators

Market Signals
Indicator
UHT
EOLS
Relative Strength Index (RSI) 48.39 70.01
Support Level $39.72 $5.78
Resistance Level $43.06 N/A
Average True Range (ATR) 1.04 0.46
MACD -0.03 0.12
Stochastic Oscillator 52.12 96.91

Price Performance

Historical Comparison
UHT
EOLS

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: